semaj83/ctmatch_classification huggingface dataset:
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Critical Illness Critically Ill Patients in intensive care who meet all of the following will be eligible: 1. Admitted to intensive care between 72 hours and 120 hours 2. Receiving invasive ventilator support 3. At least 18 years of age 4. Have central venous access suitable for PN solution administration 5. Have 1 or more organ system failure (respiratory, cardiovascular or renal) related to their acute illness defined as PaO2/FiO2 ≤ 300 mmHg Currently on 1 or more continuous inotrope/vasopressor infusion which were started at least 4 hours ago at a minimum dose of: 1. Noradrenaline ≥ 0.1mcg/kg/min 2. Adrenaline ≥ 0.1 mcg/kg/min 3. Any dose of vasopressin 4. Milrinone > 0.1 mcg/kg/min Renal dysfunction defined as: 1. Serum creatinine 2.0-2.9 times baseline OR 2. Urine output 0.5ml/kg/hr for ≥ 12 hours OR 3. Currently receiving renal replacement therapy Currently has an intracranial pressure monitor or ventricular drain in situ  Patients will be excluded if Both EN and PN cannot be delivered at enrolment (i.e. either an enteral tube or a central venous catheter cannot be placed or clinicians feel that EN or PN cannot be safely administered due to any other reason) Currently receiving PN Clinician believes a specific parenteral formula is indicated Death is imminent in the next 96 hours There is a current treatment limitation in place or the patient is unlikely to survive to 6 months due to underlying/chronic illness More than 80% of energy requirements have been satisfactorily delivered via the enteral route in the last 24 hours Dialysis dependent chronic renal failure Suspected or known pregnancy Product contraindication
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 0.0-90.0,  Cutaneous Leishmaniases Subject has Giemsa and PCR proven L.major cutaneous leishmaniasis Subject has complex zoonotic cutaneous leishmaniasis or Sb(V) incompatibility Subject gives voluntary consent  Immune deficiencies, skin tumours, allergy to 1,2-propylene glycol (rare)
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sepsis Septic Shock Critical Illness Fluid Overload Diagnosis of severe sepsis or septic shock within 12 hours of admission in our Intensive Care Unit (ICU) Informed consent  Age < 18 years Pregnancy Do Not Resuscitate (DNR/DNI) with limitations of care Patients with fatal underlying disease who are unlikely to survive to hospital discharge (e.g.: disseminated malignant disease) Patients primarily admitted for acute coronary syndromes, acute cerebrovascular incidents or active gastrointestinal (GI) bleeds Patients that need immediate surgical treatment Patients with HIV and a cell count of cluster of differentiation 4 (CD4) cells < 50 mm2 Patients with known glucose-6 phosphate dehydrogenase (G-6PD) deficiency Patients with severe sepsis/septic shock transferred from another hospital Patients with features of sepsis/septic shock > 24 hours
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Constipation-predominant Irritable Bowel Syndrome Age between 18 and 75 years A diagnosis of IBS-C according to Rome IV Recurrent abdominal pain, on average, at least 1 day per week in the last 3 months, associated with 2 or more of the following 1) Relation to defecation; 2) Association with a change in stool frequency; 3) Association with a change in stool form (appearance). fulfilled for the last 3 months with symptom onset at least 6 months ago. Reported stool consistency over the last 3 months: At least 25% of bowel movements are hard and lumpy stools (BSFS 1 or 2) and less than 25% of bowel movements are watery stools (BSFS 6 or 7) Negative colonoscopy in the past 5 years prior to inclusion Treatment in primary care unsuccessful for 12 months Ability to understand, read and speak the Dutch language Ability to understand how to utilize the MEASuRE app on a smartphone  Appendectomy or cholecystectomy within 2 months or other abdominal surgeries within 6 months before entry into the study A history of laxative abuse Current use of drugs that could initiate constipation (e.g. narcotics) Use of any IBS-related drugs possibly causing constipation (e.g. tricyclic antidepressants) are a reason for unless usage is on a stable dose for at least 30 days before and there is no plan to change the dose during the study period
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 3.0-7.0,  Follicular Tonsillitis (Chronic) Pediatric patients aged 3 to 7 years with ASA 1-II scheduled for tonsillectomy (or adenoidal tonsillectomy)  History of developmental disorder, cognitive impairment, cerebral palsy History of seizures(not simple febrile convulsions) Upper respiratory infections Structural airway disease predicting difficult airway History of an adverse reaction, including allergic reactions to fentanyl
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Diarrhea We will samples from participants with self-reported or clinical provider documented diarrhea defined as one or more loose or watery stools per day as defined by a or b below Cases of acute diarrhea (i.e., diarrhea which is currently active or was experienced up to one day prior to sampling or still active during sampling) will be included Cases of persistent diarrhea (i.e., diarrhea which is chronic or chronic-intermittently, i.e., once a week or more, experienced for at least 2 to 4 weeks prior to sampling), will be included. In the case of chronic diarrhea, diarrhea does not have to be active on the day of, or immediately prior to (i.e., one day) sampling. 2. Current enrollment in an active NIH protocol or enrollment in 12-NR-0195. 3. Able to provide 50ml stool sample within 2-3 hours. 4. Children will only be enrolled if they are currently enrolled in an active NIH protocol or enrolled in 12-NR-0195  This protocol will outpatients who are clinically unstable patients. Clinically unstable patient is defined as someone requiring emergent care or hospitalization. 2. Antibiotic use, which can affect intestinal flora, is not exclusionary but will be controlled for via post-hoc analysis. 3. NINR employees, subordinates/relatives/ or co-workers. 4. Any NIH employee who is a subordinates/relatives/or co-workers of study investigator
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 6.0-60.0,  PKDL - Post-Kala-Azar Dermal Leishmanioid Confirmed PKDL case by clinical presentation and demonstration of parasites by microscopy in a skin smear or by PCR, with documented stable or progressive disease for at least 6 months or grade 3 PKDL Male or Female patients aged 6 to 60 years Written voluntarily informed consent is obtained from the patient, or his guardian if the patient is < 18 years old. In the case of minors aged >12 to <18, assent from the children is also needed in addition to the guardian's consent  Patients who had prior treatment of PKDL within the last 1 year Pregnant and lactating women and women of childbearing age (12 to 55 years) who do not accept to have a pregnancy test and who do not agree to use contraception during treatment period and for 5 months after the end of treatment Patients with signs and symptoms of severe diseases: defined as suffering from a concomitant severe infection such as TB or any other serious known underlying disease (cardiac, renal, hepatic) Severe malnutrition defined by BMI for age WHO reference curves for gender, Z score < -3 for subjects 6 to < 19 years; BMI < 16 for subjects > 19 years old Patients with haemoglobin < 5g/dL Patients with known skin disease Patients with abnormal liver function (ALT and AST) tests of more than three times the normal range Patients with total bilirubin levels >1.5 times the upper normal range Patients with serum creatinine above the upper limit of normal range Patients with serum potassium < 3.5 mmol/L
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Gastrointestinal Symptoms Individuals who express gastrointestinal symptoms more than three times per week as identified through the Gastrointestinal Symptom Questionnaire (such as abdominal pain/ discomfort, heartburn, acid regurgitation, bloating, nausea and vomiting, abdominal distention, eructation (burping), increased gas, decreased passage of stools, increased passage of stools, loose stools, hard stools, urgent need for defecation, or feeling of incomplete evacuation) Healthy with few health complications Adults ages 18 or older  Anyone under the age of 18 Individuals diagnosed with celiacs, IBS, Crohn's disease, ulcerative colitis, or short bowel syndrome Individuals who have previously taken GlutenShield Individuals who are currently taking prebiotics, probiotics, enzymes, non-steroidal anti-inflammatory drugs, fish oil, and/or fiber supplements (unless use is halted in the voluntary 2-week washout period prior to the study) Individuals who are pregnant or intend to become pregnant during the duration of the study
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Diarrhea Exocrine Pancreatic Insufficiency Abdominal Pain Patients aged 18 to 80 years old who presents to the gastroenterology clinic with main complaints of diarrhea 2. Patients aged 18-80 years old who presents to the gastroenterology clinic with main complaints of flatulence, and/or bloating 3. Patients with known IBS, microscopic colitis or celiac disease diagnosis will be included. 4. Patients on Diphenxoylate, loperamide or cholestyramin will be included  Known chronic pancreatitis, recurrent acute pancreatitis or autoimmune pancreatitis. 2. Known Pancreatic cancer 3. Prior History of distal pancreatictomy or Whipple surgery. 4. Prior history of gastric bypass surgery or any Roux en Y gastrojeujunal anastomosis. 5. Pregnant Patients
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 21.0-99.0,  Acute Appendicitis Abdominal Pain of doctors Junior doctors working in the Emergency Department  Refusal of consent of patients- Presence of abdominal pain, OR Presence of gastrointestinal symptoms such as nausea, vomiting or diarrhea, OR Fever with anorexia Previous history of appendicectomy Refusal of consent
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Hepatic Encephalopathy Diagnosis of cirrhosis: Based on liver biopsy or clinical assessment of a hepatologist based on history, exam, laboratory and radiographic evidence History of at least one episode of overt HE, defined by West Haven Grades II to IV; episodes of HE that were precipitated by gastrointestinal hemorrhage requiring transfusion of at least 2 units of blood, by medication use, by renal failure requiring dialysis, or by injury to the central nervous system will not be counted as previous HE episodes Compliant with lactulose and rifaximin treatment (lactulose: at least one dose at least 5 days per week; rifaximin: at least one dose at least 5 days per week)  Current episode of overt HE as defined by West Haven Grades II to IV Expectation of liver transplantation within two months of the screening visit Current infection Variceal bleeding in the last 4 weeks Gut-absorbable or intravenous antibiotic therapy (including ciprofloxacin for SBP prophylaxis) in the last 3 months Alcohol or illicit drug intake within 3 months, by history and available serum testing; alcohol use will be characterized as >1 alcoholic drink / month PSC as etiology of liver disease, as prior literature has suggested these individuals have a unique microbiome History of Roux-en-Y Gastric bypass On immunosuppressive medications Positive C. difficile test
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Functional Gastrointestinal Disorders for FGID patients Functional bowel disease as per physician's diagnosis (medical judgement) and Rome IV Signed Informed Consent after being informed Age 18-60 years for hepatology control cohort Signed Informed Consent after being informed Age 18-60 years Patient in the ambulatory hepatology clinic for healthy volunteers Signed informed consent after being informed Age 18-60 years  for FGID patients Inflammatory bowel disease Gastrointestinal malignancy Celiac Disease Known or suspected non-compliance, drug or alcohol abuse Previous large abdominal surgery likely to impact patient symptomatology Inability to follow the procedures of the study, e.g. due to language problems, dementia, etc. of the participant Previous enrollment into the current study Use of antibiotics in the previous 4 weeks before enrolment for hepatology control cohort
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Heart Failure age between 18 and 65 years old at least1 year of diagnosed HF left ventricular ejection fraction (LVEF) lower than 40% measured by echocardiography non-ischaemic and ischaemic aetiologies compensated HF with optimal medication for at least 3 months prior the study New York Heart Association (NYHA) class of I to IV  patients with autonomic diabetic neuropathy patients with chronic renal failure with haemodialysis heart transplantation presence of pacemaker patients with muscular dystrophy (i.e. Duchenne muscular dystrophy) patients submitted to any hormonal treatment history of cancer ongoing infection myocardial infarction with percutaneous coronary intervention or revascularization 6 months prior to the study entry